SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-118496
Filing Date
2023-04-26
Accepted
2023-04-26 16:05:52
Documents
4
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d447451ddef14a.htm DEF 14A 328117
2 GRAPHIC g447451dsp001.jpg GRAPHIC 160263
3 GRAPHIC g447451dsp002.jpg GRAPHIC 77641
4 GRAPHIC g447451g84s61.jpg GRAPHIC 26533
  Complete submission text file 0001193125-23-118496.txt   678981
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39269 | Film No.: 23849708
SIC: 2834 Pharmaceutical Preparations